Albemarle (ALB) Set to Release Quarterly Earnings on Wednesday

Albemarle (NYSE:ALB) will likely be posting its Q3 2026 results after the market closes on Wednesday, November 4th. Analysts expect the company to post earnings of $2.53 per share and revenue of $1.52 billion for the quarter. Individuals can check the company’s upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Thursday, November 5, 2026 at 8:00 AM ET.

Albemarle (NYSE:ALB) last announced its quarterly earnings data on Wednesday, August 5th. The specialty chemicals company reported $3.75 EPS for the quarter, beating the consensus estimate of $3.20 by $0.55. The firm had revenue of $1.74 billion for the quarter, compared to analysts’ expectations of $1.61 billion. The business’s revenue for the quarter was up 31.1% compared to the same quarter last year. During the same period last year, the company posted $0.11 earnings per share. On average, analysts expect Albemarle to post $11.19 EPS for the current fiscal year and $11.51 EPS for the next fiscal year.

Albemarle Stock Performance

NYSE:ALB opened at $99.05 on Wednesday. Albemarle has a fifty-two week low of $88.01 and a fifty-two week high of $221.00. The firm has a 50-day simple moving average of $114.29 and a two-hundred day simple moving average of $150.86.

Albemarle Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, January 4th. Shareholders of record on Friday, December 18th will be issued a $0.41 dividend. The ex-dividend date of this dividend is Friday, December 18th. This represents a $1.64 annualized dividend and a yield of 1.7%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on ALB shares. Citigroup dropped their target price on shares of Albemarle from $175.00 to $125.00 and set a “buy” rating on the stock in a research note on Thursday, October 22nd. Zacks Research downgraded shares of Albemarle from a “hold” rating to a “strong sell” rating in a research report on Friday, October 9th. BMO Capital Markets restated an “outperform” rating and issued a $175.00 price objective on shares of Albemarle in a report on Tuesday, October 6th. Wall Street Zen upgraded shares of Albemarle from a “hold” rating to a “buy” rating in a report on Saturday, October 10th. Finally, Mizuho raised Albemarle from a “neutral” rating to an “outperform” rating and set a $130.00 price objective on the stock in a research report on Wednesday, October 14th. Fifteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $179.41.

About Albemarle

Albemarle Corporation (NYSE: ALB) is a global specialty chemicals company headquartered in Charlotte, North Carolina. The company develops, manufactures, and markets engineered chemicals used in energy storage, transportation, refining, pharmaceuticals, agriculture, consumer products, and other industrial applications.

Albemarle is one of the world’s major producers of lithium and supplies lithium compounds, including lithium carbonate and lithium hydroxide, for use in rechargeable batteries for electric vehicles, portable electronics, and grid energy-storage systems.